Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

610 ARTÍCULOS , VIENDO DEL 601 AL 610

Cardiovascular Risk as a Moderator of the Relationship Between Plasma Alzheimer Disease Biomarkers and Cognitive Status

Kancheva AK, Lyall DM, Tsvetanov KA, Kancheva IK, Mavromati K, Koychev I, Tari B, Garcia DJ, Hughes L, Wardlaw JM, Quinn TJ.

J Am Heart Assoc. 2026 Jan 6;15(1):e044438. doi: 10.1161/JAHA.125.044438. Epub 2025 Dec 30.

Malondialdehyde in cognitive impairment: A systematic review and meta-analysis

Zoroddu S, Sedda S, Mangoni AA, Carru C, Zinellu A.

Neurosci Biobehav Rev. 2026 Feb;181:106531. doi: 10.1016/j.neubiorev.2025.106531. Epub 2025 Dec 20.

Prevalence of Alzheimer's disease pathology in the community

Aarsland D, Sunde AL, Tovar-Rios DA, Leuzy A, Fladby T, Zetterberg H, Blennow K, Tan K, De Santis G, Yakoub Y, Arslan B, Huber H, Pola I, Grötschel L, Di Molfetta G, Skjellegrind HK, Selbaek G, Ashton NJ.

Nature. 2026 Feb;650(8100):182-186. doi: 10.1038/s41586-025-09841-y. Epub 2025 Dec 17.

Language dysfunction as a primary feature of cognitive decline in neurological populations

Leavitt VM, Simani L, Haghighi AB, Koch M, König A, Rusz J.

J Neural Transm (Vienna). 2026 Mar;133(3):397-407. doi: 10.1007/s00702-025-03015-w. Epub 2025 Sep 6.

Pathophysiological mechanisms linking osteoarthritis and neurodegenerative disease risk

Prasoon P, Nguyen KL, Fathi PA, Gupta S, Arnab S, Jones E, Meyyappan A, Stehle EJ, Bethea JR.

Osteoarthritis Cartilage. 2026 Feb;34(2):193-212. doi: 10.1016/j.joca.2025.10.009. Epub 2025 Oct 28.

Validation of the Psychosis and Hallucinations Questionnaire in Lewy Body Dementia

Gunawardana CW, Burke PGR, Matar E, Lewis SJG.

J Geriatr Psychiatry Neurol. 2026 Jul;39(4):368-379. doi: 10.1177/08919887251395314. Epub 2025 Nov 7.

EEG-based stratification in Alzheimer's disease: Cognitive progression, pathological marker associations, and therapeutic interventions

Pei Z, Zhu L, Ren H, Liu Y, Shi X, Lin Y, Wang J, Li P, Wang P, Ji Y, Zhou Y, Tang X, Jiang X, Tong X, Guo Y.

Clin Neurophysiol. 2026 Jan;182:2111440. doi: 10.1016/j.clinph.2025.2111440. Epub 2025 Nov 15.

Speech and language outcome measures in clinical trials of Alzheimer's and Parkinson's diseases

Berthier ML, Sosa-Welford A, Orozco-Arroyave JR, López-Barroso D, Torres-Prioris MJ, Dávila G, García AM.

Expert Rev Neurother. 2026 Jan;26(1):15-34. doi: 10.1080/14737175.2025.2600616. Epub 2025 Dec 16.

The association between smoking and Huntington's disease symptom onset and progression - results from Enroll-HD: The observational cohort study of people with Huntington's disease

Witkowski G, Zielonka D, Rola R, Sienkiewicz-Jarosz H.

Neurol Neurochir Pol. 2026;60(1):83-91. doi: 10.5603/pjnns.107176. Epub 2025 Oct 14.

Effects of computerized cognitive training on functional activity and connectivity in Huntington's disease: A pilot study

Huynh K, Georgiou-Karistianis N, Lampit A, Siddiqui MN, Voigt K, Stout JC, Jamadar SD.

J Huntingtons Dis. 2026 Feb;15(1):124-136. doi: 10.1177/18796397251399752. Epub 2025 Nov 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias